BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 31053545)

  • 41. Liver injury is most commonly due to hepatic metastases rather than drug hepatotoxicity during pembrolizumab immunotherapy.
    Tsung I; Dolan R; Lao CD; Fecher L; Riggenbach K; Yeboah-Korang A; Fontana RJ
    Aliment Pharmacol Ther; 2019 Oct; 50(7):800-808. PubMed ID: 31309615
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Prevalence and risk factors of drug induced liver disease: a survey based study in pharmacies].
    Jüngst C; Gräber S; Klahn D; Wedemeyer H; Lammert F
    Z Gastroenterol; 2016 Feb; 54(2):131-8. PubMed ID: 26854832
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Incidence and Pattern of Aminotransferase Elevation During Anti-Hypertensive Therapy With Angiotensin-II Receptor Blockers.
    Choi WJ; Kim GA; Park J; Jang S; Jung WJ; Shim JJ; Park Y; Choi GH; Kim JW; Jeong SH; Jang ES
    J Korean Med Sci; 2022 Aug; 37(33):e255. PubMed ID: 35996932
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Causality imputation between herbal products and HILI: An algorithm evaluation in a systematic review.
    Soares PF; Fernandes MTCF; Souza AS; Lopes CM; Dos Santos DAC; Oliveira DPR; Pereira MG; Prado NMBL; Gomes GSDS; Santos G; Paraná R
    Ann Hepatol; 2021; 25():100539. PubMed ID: 34555512
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Certolizumab-induced liver injury: as assessed for causality by the updated RUCAM.
    Shakhashiro M; Crasta R; Javed F
    BMJ Case Rep; 2023 Sep; 16(9):. PubMed ID: 37748817
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Causality Evaluation of Drug-Induced Liver Injury in Newborns and Children in the Intensive Care Unit Using the Updated Roussel Uclaf Causality Assessment Method.
    Ye L; Feng Z; Huang L; Guo C; Wu X; He L; Tan W; Wang Y; Wu X; Hu B; Li T; Yang G; Chengxian G; He Q
    Front Pharmacol; 2021; 12():790108. PubMed ID: 34987403
    [No Abstract]   [Full Text] [Related]  

  • 47. The characteristics and clinical outcome of drug-induced liver injury: a single-center experience.
    Idilman R; Bektas M; Cinar K; Toruner M; Cerit ET; Doganay B; Erden E; Bozkaya H; Bahar K; Karayalcin S; Soykan I; Palabiyikoglu M; Cetinkaya H; Yurdaydin C; Dokmeci A; Ozden A
    J Clin Gastroenterol; 2010 Jul; 44(6):e128-32. PubMed ID: 20551776
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Incidence of antituberculosis-drug-induced hepatotoxicity and associated risk factors among tuberculosis patients in Dawro Zone, South Ethiopia: A cohort study.
    Wondwossen Abera ; Waqtola Cheneke ; Gemeda Abebe
    Int J Mycobacteriol; 2016 Mar; 5(1):14-20. PubMed ID: 26927985
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Real-World Data of Tigecycline-Associated Drug-Induced Liver Injury Among Patients in China: A 3-year Retrospective Study as Assessed by the Updated RUCAM.
    Shi X; Zuo C; Yu L; Lao D; Li X; Xu Q; Lv Q
    Front Pharmacol; 2021; 12():761167. PubMed ID: 34795591
    [No Abstract]   [Full Text] [Related]  

  • 50. Severe tyrosine-kinase inhibitor induced liver injury in metastatic renal cell carcinoma patients: two case reports assessed for causality using the updated RUCAM and review of the literature.
    Studentova H; Volakova J; Spisarova M; Zemankova A; Aiglova K; Szotkowski T; Melichar B
    BMC Gastroenterol; 2022 Feb; 22(1):49. PubMed ID: 35123392
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nitrofurantoin-induced liver injury: long-term follow-up in two prospective DILI registries.
    Bessone F; Ferrari A; Hernandez N; Mendizabal M; Ridruejo E; Zerega A; Tanno F; Reggiardo MV; Vorobioff J; Tanno H; Arrese M; Nunes V; Tagle M; Medina-Caliz I; Robles-Diaz M; Niu H; Alvarez-Alvarez I; Stephens C; Lucena MI; Andrade RJ
    Arch Toxicol; 2023 Feb; 97(2):593-602. PubMed ID: 36416910
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Drug Induced Liver Injury in Geriatric Patients Detected by a Two-Hospital Prospective Pharmacovigilance Program: A Comprehensive Analysis Using the Roussel Uclaf Causality Assessment Method.
    Pedraza L; Laosa O; Rodríguez-Mañas L; Gutiérrez-Romero DF; Frías J; Carnicero JA; Ramírez E
    Front Pharmacol; 2020; 11():600255. PubMed ID: 33613279
    [No Abstract]   [Full Text] [Related]  

  • 53. Drug-induced liver injury: present and future.
    Suk KT; Kim DJ
    Clin Mol Hepatol; 2012 Sep; 18(3):249-57. PubMed ID: 23091804
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Roussel Uclaf Causality Assessment Method for Drug-Induced Liver Injury: Present and Future.
    Danan G; Teschke R
    Front Pharmacol; 2019; 10():853. PubMed ID: 31417407
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Risk of Liver Injury Associated with Green Tea Extract in SLIMQUICK(®) Weight Loss Products: Results from the DILIN Prospective Study.
    Zheng EX; Rossi S; Fontana RJ; Vuppalanchi R; Hoofnagle JH; Khan I; Navarro VJ
    Drug Saf; 2016 Aug; 39(8):749-54. PubMed ID: 27189593
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [RUCAM scale-based diagnosis, clinical features and prognosis of 140 cases of drug-induced liver injury].
    Hao K; Yu Y; He C; Wang M; Wang S; Li X
    Zhonghua Gan Zang Bing Za Zhi; 2014 Dec; 22(12):938-41. PubMed ID: 25654289
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Liver injury in patients with COVID-19 in comparison to patients with the pandemic influenza A (H1N1) 2009: a population-based study.
    Sigurdarson J; Eythorsson E; Bjarnason A; Bjornsson ES
    Scand J Gastroenterol; 2023; 58(10):1145-1152. PubMed ID: 37128725
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Risk of drug-induced liver injury from tumor necrosis factor antagonists.
    Björnsson ES; Gunnarsson BI; Gröndal G; Jonasson JG; Einarsdottir R; Ludviksson BR; Gudbjörnsson B; Olafsson S
    Clin Gastroenterol Hepatol; 2015 Mar; 13(3):602-8. PubMed ID: 25131534
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Drug-Induced liver injury with hypersensitivity features has a better outcome: a single-center experience of 39 children and adolescents.
    Devarbhavi H; Karanth D; Prasanna KS; Adarsh CK; Patil M
    Hepatology; 2011 Oct; 54(4):1344-50. PubMed ID: 21735470
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Herb induced liver injury by Xianling Gubao Tablets: A case assessed for causality using updated RUCAM and integrated evidence chain.
    Li C; Li Y; Bai Z; Wang J; Li G; Xiao X
    Chin Herb Med; 2024 Apr; 16(2):301-309. PubMed ID: 38706827
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.